Navigation Links
Intarcia Therapeutics Announces Final Results From a Phase 2 Study,of Injectable Omega Interferon plus Ribavirin for the Treatment of,Hepatitis C Genotype-1

ients."

About Omega DUROS Therapy

Omega DUROS therapy is being developed to improve the treatment of HCV by offering a more convenient and potentially safer and more effective treatment. Omega DUROS therapy is designed to deliver a continuous and consistent dose of omega interferon for three months via the implantable DUROS device, a drug delivery technology developed by ALZA Corporation, and licensed to Intarcia for use in certain broad fields. Another product incorporating the DUROS technology has already approved by the FDA for the palliative treatment of prostate cancer. Intarcia is also leveraging the DUROS technology in evaluating other drug development opportunities. The most advanced of these is focused on the delivery of GLP-1 and a GLP-1 analog with the DUROS device for the treatment of type 2 diabetes.

About Intarcia

Intarcia Therapeutics, Inc. is a biopharmaceutical company developing therapeutics for patients with chronic diseases in which there are significant unmet medical needs. Intarcia's drug development expertise and competitive edge are complemented by its ability to stabilize macromolecules and to deliver them in a constant and consistent manner via the proprietary DUROS drug delivery platform. The initial programs that Intarcia is pursuing are in hepatitis C and type 2 diabetes.

About Hepatitis C

Hepatitis C is a major global public health problem. According to the World Health Organization, more than 170 million people worldwide are chronically infected with HCV, and three to four million new HCV infections occur annually. The U.S. Centers for Disease Control and Prevention has estimated that in the United States approximately 3.4 million people are chronically infected with HCV and approximately 25,000 new patients are infected each year. It is estimated that 10,000 to 12,000 patients die annually in the United States from complications resulting from HCV infection. The current standard of care for tr
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Intarcia Therapeutics Announces Presentation of Final Results From a Phase 2 Combination Study for the Treatment of Hepatitis C at the Digestive Disease Week Conference
2. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
3. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
4. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
5. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
6. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
7. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
8. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
9. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
10. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
11. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
Post Your Comments:
(Date:5/5/2015)...  ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP ) ... March 31, 2015 and reaffirmed its revenue, non-GAAP EBITDA, ... First Quarter 2015 Highlights Include: , First ... as compared to $10.9 million for the same period ... of $11.5 million, an increase of 170% as compared to ...
(Date:5/5/2015)... , May 5, 2015  InfuSystem Holdings, Inc. (NYSE ... and related services for the U.S. healthcare industry, today ... on Tuesday, May 12, 2015 after the market closes. ... call for investors on Tuesday, May 12, 2015 at ... and results.  To participate in this call, please dial ...
(Date:5/5/2015)... VEGAS , May 5, 2015 ... today announced the recipient of its 6 th ...  Brad Volkmer, President and CEO of Ear Professionals ... provider of hearing benefits in the nation, EPIC ... direct contracts with managed care organizations, employers, health ...
Breaking Medicine Technology:ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 2ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 3ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 4ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 5ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 6ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 7ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 8ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 9EPIC Hearing Healthcare CEO Brad Volkmer Awarded 6th Annual Most Influential In Specialty Health 2
... ARBOR, Mich., Dec. 13, 2011 Molecular Imaging, ... providing multi-modality preclinical in vivo imaging ... that it has entered into a licensing agreement ... number of luciferase-enabled cancer cell lines developed at ...
... 2011  Cardiac Science Corporation, a global leader in automated ... monitoring devices , will supply hundreds of Powerheart® G3 ... to reduce deaths from sudden cardiac arrest (SCA) among ... Australia. (Logo:  http://photos.prnewswire.com/prnh/20080306/AQTH510LOGO ) ...
Cached Medicine Technology:Molecular Imaging, Inc. Enters Relationship with Dana-Farber Cancer Institute to Expand Luciferase-reporter Cancer Cell Lines for Preclinical in vivo Imaging 2Molecular Imaging, Inc. Enters Relationship with Dana-Farber Cancer Institute to Expand Luciferase-reporter Cancer Cell Lines for Preclinical in vivo Imaging 3Australia's Sporting Clubs Select Cardiac Science AEDs 2Australia's Sporting Clubs Select Cardiac Science AEDs 3Australia's Sporting Clubs Select Cardiac Science AEDs 4
(Date:5/5/2015)... (PRWEB) May 05, 2015 Specialty ... collaborating with American Eagle Outfitters on a collection ... natural beauty. , For the debut five-piece ... Aerie by American Eagle ; the retailer's ... body-image campaign, called "Aerie REAL," uses models of ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 Igantia ... San Francisco, leads an international initiative to examine key ... extend the human lifespan. Scientists at Igantia believe ... women, from the initiation of her menstrual cycle to ... mechanism for aging and, ultimately, extend the lifespan. ...
(Date:5/5/2015)... Atlanta, GA (PRWEB) May 05, 2015 ... new hospital leadership guidebook called “Medicare Breakeven ... Performance.” The guidebook includes:, , ... you probably aren’t measuring but should be ... squeezes out unproductive “white space” and ensures ...
(Date:5/5/2015)... Every year, news articles appear warning about the summer ... eye season is spring, also known as allergy season, when ... States. The only season offering a respite from seasonal dry ... the Sharon Kleyne Hour™ Power of Water® radio show, will ... 11, 2015. Kleyne is the inventor of Nature’s Tears® EyeMist® ...
(Date:5/5/2015)... 2015 Dealing with injuries and medical expenses ... task. Personal injury lawyers are excellent resources for accident victims ... In their latest article , the Jones Firm gives the ... choosing a personal injury lawyer to handle their case. , ... a waste of time if the lawyer does not have ...
Breaking Medicine News(10 mins):Health News:BLKBOXLabs Finds Real Beauty in Beauty For Real and American Eagle Outfitters’ Aerie-Branded Beauty Line 2Health News:BLKBOXLabs Finds Real Beauty in Beauty For Real and American Eagle Outfitters’ Aerie-Branded Beauty Line 3Health News:Igantia Announces Digital Initiative to Decode Longevity 2Health News:Care Logistics Publishes a New Hospital Guidebook for Achieving Medicare Breakeven 2Health News:Nature’s Tears EyeMist tear film supplement soothes dry eye caused by spring pollen season, reports inventor Sharon Kleyne 2Health News:Nature’s Tears EyeMist tear film supplement soothes dry eye caused by spring pollen season, reports inventor Sharon Kleyne 3Health News:5 Top Qualifications for Personal Injury Lawyer Disclosed in Latest Article by The Jones Firm 2
... NBTY, Inc. (NYSE: NTY ) ( www.NBTY.com ... supplements, today announced that it will web cast the presentation ... at the Barclays Capital 2009 Retail And Restaurants ... is scheduled to be web cast live on the Company ...
... RALEIGH, N.C., April 27 Susan Brady ... publication professionals in the nation to become certified ... a nonprofit organization that provides advocacy and education ... has demonstrated in-depth knowledge and expertise on best ...
... and Human Services Department declares a Public Health EmergencyHARRISBURG, ... Pennsylvania is working with federal officials to contain the ... that resulted in the declaration of a national public ... is working to educate the public and health care ...
... health advocacy and qualityOAKLAND, Calif., April 27 ... television commercials to its Thrive advertising ... titled "Mural" and "Kabuki," reinforce Kaiser Permanente,s commitment ... the organization,s dedication to helping its members achieve ...
... cardiac surgeons can agree! There is often disagreement ... about the proper therapy for coronary artery disease ... current edition of Deutsches rzteblatt International , ... and cardiac surgeons provides answers to the question ...
... The Jewish Home has named Nitin Nanda, M.D., as ... Nanda will also serve as medical director of the ... Home,s Joyce Eisenberg-Keefer Medical Center on the Grancell Village ... Dr. Nanda will be responsible for the supervision and ...
Cached Medicine News:Health News:NBTY to Webcast Presentation at Barclays Capital 2009 Retail And Restaurants Conference 2Health News:NBTY to Webcast Presentation at Barclays Capital 2009 Retail And Restaurants Conference 3Health News:MedThink Communications Account Director Among First to Receive CMPP Certification in Medical Publications Planning and Development 2Health News:Pennsylvania Working Closely With Federal Partners to Contain Impact of Swine Flu 2Health News:Pennsylvania Working Closely With Federal Partners to Contain Impact of Swine Flu 3Health News:Kaiser Permanente Continues to Spread Health With New Ads Debuting in April 2Health News:Kaiser Permanente Continues to Spread Health With New Ads Debuting in April 3Health News:New Chief of Geriatric Psychiatry and Behavioral Health is Announced 2
The 300 watt Xenon light source will provide intense illumination necessary for demanding, advanced endoscopic procedures....
... new MicroLux® Digital Video Recorder gives you an ... store your surgical cases. THE DVR is the ... presentations. With its convenient mouse and footswitch, you ... you need - no more hours of reviewing ...
LCD monitors....
The A3 3-Chip Camera includes digital processing, seamless autoshutter, industry-leading reliability, white balance with memory function, ease of operation, and a 2 year warranty....
Medicine Products: